Navigation Links
Catholic Health Association Applauds HHS Decision on Plan B
Date:12/9/2011

WASHINGTON, Dec. 9, 2011 /PRNewswire-USNewswire/ -- Sister Carol Keehan, DC, president and chief executive officer of the Catholic Health Association of the United States (CHA), issued the following statement.

The Catholic Health Association is very grateful to HHS Secretary Kathleen Sebelius for her intelligent and courageous decision to prevent very young adolescents from purchasing and administering unsupervised the strong hormone contained in the drug known as Plan B.

There is grave concern about the safety of very young adolescents self-administering this hormone at such a critical time in their growth cycle. This is not a case of politics versus science. There is no strong science that definitively establishes the safety of this drug when self-administered by 11- and 13-year olds. 

CHA has great respect for the FDA, but there are no significant studies in 11 to 13-year olds over a long period of time that have demonstrated the safety of this very significant drug. We do not want to learn in 10 to 20 years about this drug what we now know about hormone replacement therapy and its connection to breast cancer. In addition, there are no long term studies that demonstrate the drug's potential impact on future reproductive choices these young girls will make.

Our country must help parents exercise their responsibility to their children. Giving parents control over relatively inconsequential areas such as ear-piercing and then taking it away in such a serious area would not only put their children at risk but undermine parents' ability to parent. This great country is built on the strength of the family and this decision helps to maintain a strong role for parents in critical decisions. 

The Catholic Health Association of the United States (CHA), founded in 1915, supports the Catholic health ministry's commitment to improve the health status of communities and create quality and compassionate health care that works for everyone. The Catholic health ministry is the nation's largest group of not-for-profit health systems and facilities that, along with their sponsoring organizations, employ more than 750,000 women and men who deliver services combining advanced technology with the Catholic caring tradition. For more information, visit the CHA website at www.chausa.org.


'/>"/>
SOURCE Catholic Health Association of the United States
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
2. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
3. HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
5. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
6. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
7. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health
10. Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations
11. Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... 2016 According to a new market ... - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast ... U.S. was valued at US$ 5.89 Bn in 2014 and ... 2015 to 2023 to reach US$ 7.99 Bn in 2023. ... emerging needle free drug delivery devices and the market is ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... to students studying complementary medicine. Allison Outerbridge is this year’s Life University ... on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
Breaking Medicine News(10 mins):